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doi:10.1Objectives: Aortic atresia (AA) in hypoplastic left heart syndrome (HLHS) has been associated with increased
mortality in several prior studies. We reviewed our autopsy series to explore the relationship of coronary abnor-
malities to anatomic subsets of HLHS with AA.
Methods:We retrospectively reviewed all pathology specimens with AA/MS (mitral stenosis) and AA/MA (mi-
tral atresia) in the Cardiac Registry of Children’s Hospital Boston between 1955 and 2009 including autopsy
reports, operative notes, and imaging studies. Formalin-fixed hearts were examined, and cases found to have
macroscopic coronary artery abnormalities were sectioned at mid–left ventricular level in the transverse plane
and at mid–right ventricular level in the longitudinal plane for histologic analysis of coronary arteries using tis-
sue sections stained with hematoxylin and eosin.
Results: A total of 216 autopsy cases were identified with AA/MS (134) and AA/MA (82). Coronary anomalies
were found in 49 cases, left ventricle–coronary fistula in 39, all in AA/MS, and 10 other coronary abnormalities,
all in AA/MA. Histologic study confirmed fistulas only in the AA/MS group with no evidence of fistulas in the
AA/MA group.
Conclusions: The occurrence of left ventricle–coronary fistulas appears limited to the AA/MS group, and cor-
onary fistula specimens were disproportionately more prevalent in postoperative specimens. Further clinical
studies are required to validate this finding and to identify subgroups that carry a higher mortality risk. (J Thorac
Cardiovasc Surg 2012;144:1301-6)Prior reports on hypoplastic left heart syndrome (HLHS) at
our and other institutions have found that the aortic atresia/
mitral stenosis (AA/MS) subgroup was associated with
a higher mortality. Vida and associates1 reported a higher
(29% vs 7.9%) mortality in the AA/MS variant of HLHS
compared with other anatomic subtypes of HLHS. Glatz
and colleagues2 reported a 21% vs 3% mortality in the
AA/MS subgroup vs the aortic atresia/mitral atresia
(AA/MA) subgroup.
The pathophysiologic mechanisms underlying these find-
ings have not been clearly defined, but a relationship to cor-
onary abnormalities has been postulated. Several coronary
abnormalities have been documented in HLHS, with
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The Journal of Thoracic and Carcoronary connections. O’Connor and coworkers3 in 1982
found that the AA/MS subgroup had a greater number of
coronary abnormalities including ventricular–coronary
connections. Baffa and associates4 reviewed 151 autopsy
specimens, 89 with AA/MS and 52 with AA/MA. They
identified 27 coronary–cameral fistulas in the AA/MS sub-
group, 17 with associated tortuous epicardial vessels, and 3
specimens had single coronaries. Other abnormalities that
have been described include intramural coronaries, high or-
igin of coronaries, and anomalous origin of the left coronary
artery from the pulmonary artery.5
We hypothesized that the occurrence of ventricular–cor-
onary fistula would be more common in the AA/MS sub-
group because of the frequent occurrence of hypertensive
left ventricles (LVs) in this group. Ventricular–coronary
fistulas could contribute to coronary steal and myocardial
dysfunction and may contribute to mortality in this sub-
group. To better understand the relationship between coro-
nary disease and mortality, we undertook a review of all
autopsies performed on patients with HLHS and AA at
our center.METHODS
We retrospectively reviewed, with institutional review board approval,
all cases of AA subtype of HLHS that underwent autopsy in the Cardiac
Registry of Children’s Hospital Boston between 1955 and 2009. Clinical
charts were reviewed for clinical history and operative data. Reports of
all preoperative and postoperative imaging studies and autopsies werediovascular Surgery c Volume 144, Number 6 1301
Abbreviations and Acronyms
AA ¼ aortic atresia
EFE ¼ endocardial fibroelastosis
HLHS ¼ hypoplastic left heart syndrome
LV ¼ left ventricle (ventricular)
LVEFE ¼ left ventricular endocardial fibroelastosis
MA ¼ mitral atresia
MS ¼ mitral stenosis
RV ¼ right ventricle (ventricular)
RVEFE ¼ right ventricular endocardial
fibroelastosis
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Dreviewed. In addition, all available formalin-fixed HLHS/AA heart speci-
mens were examined, including gross examination of coronaries in all
hearts.
MS was defined by documented flow across the mitral valve in imaging
studies or by the presence of a well-defined mitral valve with a patent in-
flow into the LV and a measurable orifice.
Histologic examination of all AA hearts with coronary abnormalities
noted on echocardiography, cardiac catheterization, or on gross autopsy ex-
amination was performed. In addition, coronary histologic examination
was also carried out on an equivalent number of AA hearts matched for
age and surgical status. Two representative tissue blocks, the first a cross
section of the LVat mid cavity including the septum and the second a lon-
gitudinal section from the right ventricle (RV) at the acute margin, includ-
ing the atrioventricular sulcus, were taken from intact heart specimens that
had been fixed in 10% buffered formalin. The tissue was embedded in par-
affin, and for each block, 5-mm–thick sections were cut and stained with
hematoxylin and eosin and examined with an Olympus BX400 microscope
(Olympus Corporation, Tokyo, Japan) with field diameters calibrated using
a stagemicrometer. Measurements were made of (1) thicknesses of the ven-
tricular wall, (2) thickness of the medial layer of coronary arteries having
an outer diameter between 1100 mm and 2200 mm, and (3) thickness of any
ventricular fibroelastosis approximated to the nearest fraction (1/6, 1/4, 1/3,
1/2, 2/3, or 3/4) of the microscopic field in which the thickness of interest
was completely visualized (eg, fibroelastosis that spanned half of a 2200-
mm–wide microscopic field was determined to have a thickness of 1100
mm). A fistula between a coronary artery and a ventricular cavity was con-
sidered present if therewas an unambiguous connection onmicroscopic ex-
amination or if there was overlap of a coronary artery and a ventricular
cavity in the plane of the slide. In histologically ambiguous cases or for
cases in which fistulas were grossly identified but not seen in the initial he-
matoxylin and eosin slide, additional hematoxylin and eosin slides were
prepared from the respective blocks at 10-mm intervals and examined as
above.
The hearts were classified into 4 groups:
 Group 1: AA/MS (aortic atresia, mitral stenosis)—hearts with a diagno-
sis of AA/MS confirmed by gross examination.
 Group 2: AA/MS/CF (aortic atresia, mitral stenosis, coronary fistula)—
hearts in the AA/MS group that had coronary abnormalities on echocar-
diography, cardiac catheterization, gross examination, or histologic
examination.
 Group 3: AA/MA (aortic atresia, mitral atresia)—hearts with diagnosis
of AA/MA confirmed by gross examination.
 Group 4: AA/MA/CA (aortic atresia, mitral atresia, coronary abnormal-
ities)—hearts in the AA/MA group that had coronary abnormalities on
echocardiography, cardiac catheterization, gross examination, or histo-
logic examination.1302 The Journal of Thoracic and Cardiovascular SurThis grouping system was used for comparison between groups and for
statistical analysis of histologic findings.
A nonparametric test (Mann-Whitney) was used to compare the median
coronary artery medial thickness and thickness of LVendocardial fibroelas-
tosis (LVEFE) among the 4 groups. The Pearson c2 test was used to com-
pare the proportions of 4 groups in the pre-Norwood (preoperative) and
post-Norwood (palliative surgical) eras. The statistics package used for
analysis was PASW Statistics 18.0, SPSS Inc, Chicago, Ill.RESULTS
A total of 216 hearts with the diagnosis of HLHS and AA
were examined at the cardiac registry at Children’s Hospital
Boston between 1955 and 2009. Of these, 200 were autopsy
specimens, and 16 were hearts explanted at orthotopic heart
transplantation. All but 2 of the 216 hearts were available
for reexamination. One hundred thirty-four (62%) were
of the AA/MS subtype and the remaining 82 (38%) were
of the AA/MA subtype. Thirty-nine (29%) of 134 speci-
mens of the AA/MS subtype had coronary abnormalities,
and all were fistulas between the ventricle and coronary ar-
teries, with 38 LV–coronary fistulas and 1 RV–coronary fis-
tula. Figure 1, A and B, shows representative cardiac
catheterization images of LV–coronary fistulas. In the
AA/MA group, 10 specimens had coronary abnormalities
(12%), but none had coronary fistulas. The abnormalities
noted in the AA/MA group included anomalous origin of
the left coronary artery from the pulmonary artery in 1, sin-
gle coronary artery in 3 (1 with an atretic left coronary os-
tium), aneurysmal right coronary artery in 1, high takeoff
and intramural right coronary artery in 1, intramyocardial
left anterior descending coronary artery in 1, coronary ostial
stenosis in 1, hypoplastic coronaries in 1, and high takeoff
and oblique ostium of left coronary artery in 1.
A total of 96 hearts were examined histologically: 31 in
AA/MS, 37 in AA/MS/CF, 16 in AA/MA, and 10 in AA/
MA/CA groups. Figure 2, A and B, shows histologic images
of coronary fistulas.
Tables 1 and 2 give an outline of management strategies
that had been used before the time of death/explant, and
management stage at death/explant, in the 4 anatomic sub-
groups. Tables 3 and 4 document coronary medial thickness
and EFE thickness in the 4 groups.
On comparison of the 4 groups on the basis of historical
era, ventricular–coronary fistulas were found much more
frequently in the AA/MS group in the postoperative era
than in the era before first attempts at surgical palliation
(P<.031). This finding of a higher percentage of autopsied
hearts in the operated groups compared with the nonoper-
ated specimens suggests an unfavorable impact of ventricu-
lar–coronary fistulas on surgical palliative procedures. The
presence of LVEFE was significantly higher (P>.0001) in
the AA/MS and AA/MS/CF groups than in the AA/MA and
AA/MA/CA groups. However, there was no significant dif-
ference between the AA/MS and the AA/MS/CF groups in
thickness of the LVEFE. Interestingly, there was a highergery c December 2012
FIGURE 1. A, Anteroposterior view of a left ventricular angiogram dem-
onstrating retrograde filling of the left coronary artery via the fistula. Arrow
points to the fistula. B, Lateral view of the same left ventricular angiogram
demonstrating the coronary fistula filling the left coronary artery on inject-
ing the left ventricle. Arrow points to the fistula.
FIGURE 2. A, Histologic section of the left ventricle stained with hema-
toxylin and eosin (H&E) at 403 magnification. Coronary artery and ven-
tricular–coronary connections are marked by solid black arrows. B,
Elastic-stained histologic section of the left ventricle at 1003 magnifica-
tion. The coronary artery opening into the ventricular cavity is marked
by solid arrows.
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Doccurrence of RVendocardial fibroelastosis (RVEFE) in the
AA/MS/CF group than in the AA/MS group (P<.030).
DISCUSSION
Since first description of the pathophysiology ofHLHSby
Bardeleben in 1851,6 this disease complex has been exten-
sively studied. HLHS was a uniformly fatal condition until
palliative procedures were developed and perfected in the
1970s and early 1980s. In 1981Norwood and coworkers7 re-
ported their experience with 16 consecutive infants with
HLHS inwhom staged palliation was attempted. Of interest,The Journal of Thoracic and Car3 of these patients had LV–left anterior descending coronary
artery fistulas, which are included in our series. Our series
includes specimens obtained after a variety of palliative pro-
cedures, including the first Norwood procedures.Clinical and Pathologic Distribution of the AA/MS
and AA/MA Subtypes
In contrast to the current pathologic series, most clinical
series of HLHS with AA have had a higher occurrence of
AA/MA subtype. Mahle and his group8 in their series of
840 HLHS patients found 520 patients with AA; 61% of
this group had AA/MAwhereas 39% had AA/MS. A simi-
lar distribution of 65% AA/MA vs 35% AA/MS was re-
ported by Glatz and colleagues.2
Some early autopsy series have also reported a similar
distribution. Van Praagh and associates,9 in their review
of nearly 3000 hearts in the cardiac registry at Children’s
Hospital Boston, reported 102 cases of HLHS with AA
with 63% in the AA/MA subgroup and 37% in thediovascular Surgery c Volume 144, Number 6 1303
TABLE 1. AA management strategy
Management
AA/MS
(n ¼ 134)
AA/MS/CF
(n ¼ 39)
AA/MA
(n ¼ 82)
AA/MA/CA
(n ¼ 10)
I no surgery
(before Norwood era)
49* 8* 32 4
II surgical palliation 85y 31y 50 6
P value .031 (I vs II) NS (I vs II)
This table represents the distribution of the hypoplastic left hearts with aortic atresia
in the 3 subgroups in the preoperative and postoperative eras. There is a significantly
higher proportion of hearts with AA/MS and ventricular–coronary fistulas in the post-
operative era. AA,Aortic atresia;MS,mitral stenosis; CF, coronary fistula;MA,mitral
atresia; CA, coronary anomalies other than coronary fistula; NS, not significant. *Ex-
planted heart from primary orthotopic heart transplantation¼ 1. yHybrid stage I¼ 4.
TABLE 3. Histology of coronary arteries—medial thickness
Coronary artery medial thickness (mm)
AA/MS AA/MS/CF AA/MA AA/MA/CA
n 31 37 16 10
Median 37 55 37 37
Range 37-165 37-110 37-110 37-110
P value .22-.55 between groups
This table compares the coronary artery medial thickness in the 4 groups of hypoplas-
tic left hearts with aortic atresia. There is no significant difference in the medial thick-
ness of coronary arteries noted. AA, Aortic atresia; MS, mitral stenosis; CF, coronary
fistula; MA, mitral atresia; CA, coronary anomalies other than coronary fistula.
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DAA/MS subgroup. This finding is likely related to the fact
that the majority of cases reported in this series were from
the era before attempts at surgical palliation. However, later
autopsy series have contained a higher percentage of AA/
MS hearts. Bartram and colleagues10 reported 88 cases of
AA with a distribution of 49% AA/MA and 51% AA/MS
in their postmortem series of 122 deaths after modified Nor-
wood procedures. Bharati and Lev11 looked at 230 hearts
with HLHS. They reported 200 cases of AA, 95 (48%)
with AA/MA, and 105 (52%) with AA/MS.
In our series of 216 autopsy cases of HLHS/AA, we
found a much higher percentage of specimens with AA/
MS compared with AA/MA (62% vs 38%). This finding
is potentially related to the significantly higher number of
coronary abnormalities seen in the AA/MS group, 29%
vs 12% in the AA/MA group (P<.004) and to the inclusion
of a large number (63%) of postoperative specimens. The
only coronary abnormality we found in the AA/MS sub-
group was ventricular–coronary fistula. The AA/MA group
had several types of coronary abnormalities but none had
coronary fistulas.
Coronary Morphology
Prior studies of the coronary arteries in HLHS suggested
that coronary morphology was a possible contributor toTABLE 2. AA stage at death
Outcome
AA/MS
(n ¼ 134)
AA/MS/CF
(n ¼ 39)
AA/MA
(n ¼ 82)
AA/MA/CA
(n ¼ 10)
Unoperated
(before Norwood era)
49* 8* 32 4
Stage I 59 20 30 5
OHT after stage I 8 7 0 0
Interstage death 4 0 13 1
After BDG death 4 2 3 0
OHT after BDG 0 0 3 0
After Fontan death 6 0 1 0
OHT after Fontan 4 2 0 0
This table represents the proportion of hearts in the 4 subgroups based on stage at
death. Again there is higher proportion of hearts with AA/MS and ventricular–coro-
nary fistula in the postoperative era, particularly after the initial palliation. AA,Aortic
atresia; MS, mitral stenosis; CF, coronary fistula; MA, mitral atresia; CA, coronary
anomalies other than coronary fistula; OHT, orthotopic heart transplantation; BDG,
bidirectional Glenn. *Explanted heart after orthotopic heart transplantation.
1304 The Journal of Thoracic and Cardiovascular Surmortality. Lloyd, with Evans and Marvin12 and with Mar-
vin,13 compared 51 autopsy specimens with HLHS with
18 normal controls and found no difference in coronary os-
tial size or diameters in the 2 groups. A subsequent study of
59 HLHS heart specimens, all from patients who died
within the first 90 days after birth (11 surgically palliated),
demonstrated a significant survival advantage for larger
coronaries, greater RV mass, and coronary/RV mass ratio.
They concluded that adequacy of myocardial perfusion
was essential for survival. Sauer and colleagues14 compared
the epicardial coronaries in 9 AA/MA hearts, 19 AA/MS
hearts, and 10 normal hearts. They noted that LVEFE was
present in all AA/MS hearts and that coronaries in AA/
MS hearts were thicker and more tortuous on macroscopic
examination. Although there was no difference in external
diameters of the coronaries in the groups, some AA/MS
hearts did show an increase in medial thickness, particularly
in the left coronary system. They hypothesized that these
coronary abnormalities may increase risk of mortality.
Baffa and coworkers,4 in their series of 151 hearts, re-
ported no difference in coronary artery wall thickness be-
tween AA/MS, AA/MA, and AS/MS hearts. Sugiyama
and associates15 described a higher occurrence of abnormal
findings, including myocardial necrosis, interstitial fibrosis,
and calcification, in the MS subgroups of HLHS, which
could possibly contribute to RV dysfunction and thus poorer
prognosis. Recent studies by Salih, Sheppard, and Ho16 on
unoperated HLHS hearts from patients dying in the first 2TABLE 4. Histology of LV endocardium
EFE thickness (mm)
AA/MS AA/MS/CF AA/MA AA/MA/CA
n 31 37 16 10
Median 225 225 0 0
Range 0-1833 0-1833 0-73 0-73
P value <.0001 vs
AA/MA
<.0001 vs
AA/MA/CA
This table compares the thickness of the left ventricular endocardium in the four
groups of hypoplastic left hearts with aortic atresia. There is a significant difference
in the occurrence of left ventricular fibroelastosis in the subgroup with aortic atresia
and mitral stenosis. LV, Left ventricle (ventricular); EFE, endocardial fibroelastosis;
AA, aortic atresia; MS, mitral stenosis; CF, coronary fistula; MA, mitral atresia; CA,
coronary anomalies other than coronary fistula.
gery c December 2012
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Dmonths after birth found that capillarization (as measured
by diffusion distance) in both the RV and LV was reduced
compared with normal hearts. They hypothesized that
increased diffusion distances could affect ventricular devel-
opment inasmuch as tissue aerobic metabolism is depen-
dent on diffusion distance from capillary beds.
Our series showed no significant differences in coronary
artery medial thickness between the various subtypes of
HLHS with AA, but capillary density and capillary diffu-
sion distances were not examined.
Coronary Fistula
Occurrence of coronary fistulas in AA was reported as
early as 1932 by Bellet and Gouley.17 Raghib and col-
leagues18 described a case of AA with premature closure
of the foramen ovale, with egress of LV blood through sinu-
soids and coronary fistulas and ultimately via the coronary
sinus to the right atrium. They compared this with RV–cor-
onary fistulas seen with pulmonary atresia and intact ven-
tricular septum. More recently, LV–coronary fistulas in
HLHS have been successfully diagnosed on prenatal ech-
oes.19 Extensive ventricular–coronary connections to both
coronary artery systems was recently reported by Roberson
and his group.20 Their patient underwent hybrid stage I pal-
liation and died at 5 weeks of age of ischemia-induced ven-
tricular tachyarrhythmia. The left circumflex system had
a proximal obstruction and was exclusively supplied
through fistulous communication from the LV.
In our series we had only 1 heart with AA/MS with
demonstrable coronary ostial occlusion on cardiac catheter-
ization and coronaries filling entirely from the hypertensive
LV via fistulous communication. Although 2 of the hearts
in our AA/MA subgroup had coronary ostial atresia or ste-
nosis, it is interesting to note that neither had coronary
fistula.
Sathanandam and coworkers,21 in a 4-year prospective
study, reported 15% incidence of ventricular–coronary con-
nections in 100 consecutive HLHS cases, with 56% of the
AA/MS subtype having ventricular–coronary connections.
Mortality was limited to those cases with extensive ventric-
ular–coronary connections. Recent work by Scheurer and
colleagues22 at our institution retrospectively reviewed all
cases of AA/MS over a 42-month period beginning in Jan-
uary of 2007 with a significantly lower transplant-free sur-
vival (34%) in those with LV–coronary fistulas compared
with 100% in those without fistulas. In our series, AA/
MS hearts with ventricular–coronary fistulas were dispro-
portionately represented among the specimens in the AA/
MS subgroup after palliation. This finding suggests that
the presence of LV–coronary fistulas may have contributed
to mortality in the AA/MS subgroup in our series. Appendix
Table 1 outlines the percentage of coronary fistulas in AA/
MS group and coronary abnormalities in the AA/MA group
distributed over 10-year periods. Appendix Table 2 outlinesThe Journal of Thoracic and Carthe distribution in the pre-Norwood and post-Norwood era.
As depicted in the tables, the occurrence of coronary abnor-
malities in autopsies in the AA/MA group is essentially un-
changed over time, but the occurrence of coronary fistulas
in autopsies and explanted hearts in the AA/MS group has
gradually increased from 12.5% in the preoperative/pre-
Norwood era to nearly 60% in the current era. However, be-
cause this is an autopsy series and the true denominator is
unknown, we can only speculate that occurrence of coro-
nary fistulas in the AA/MS group confers a higher risk of
mortality.
The mechanism by which these ventricular–coronary
connections/fistulas could contribute to an increased mor-
tality risk remains unclear, particularly in patients after
stage I palliative procedures. In contrast to patients with
pulmonary atresia and RV-dependent coronary circulation,
in whom proximal coronary stenosis or atresia is associated
with higher mortality,23 patients with AA/MS and ventricu-
lar–coronary fistulas did not demonstrate proximal obstruc-
tions. Inasmuch as there was a high incidence of restrictive
atrial septum in these patients with coronary fistulas, it is
tempting to speculate that the atrial septectomy that is car-
ried out as part of a typical Norwood or Sano stage I palli-
ative procedure alters LV filling and thus coronary perfusion
through ventricular–coronary fistulas. In addition, it is
known that the AA/MS subgroup generally has a hyperten-
sive LV with suprasytemic pressures, which may lead to re-
versal of flow in coronaries and coronary malperfusion.
This high pressure in the LV cavity may also lead to suben-
docardial ischemia and fibrosis because of abnormal trans-
mural gradients.24
Limitations
This study has limitations in that it is an autopsy series,
data were collected retrospectively from a single center,
and physiologic relationship between coronary fistula and
mortality cannot be clearly established.
CONCLUSIONS
Coronary fistulas appear to be the most common coro-
nary abnormality in this autopsy series of AA in HLHS.
Ventricular–coronary fistulas are limited to the AA/MS
group. Patients with AA/MS and coronary fistulas were
overrepresented in the autopsies from the postoperative
era compared with the preoperative era. The exact relation-
ship between abnormal coronaries, particularly LV–coro-
nary fistulas, and mortality cannot be conclusively
established, but it is seems likely that coronary fistulas
may have contributed to coronary ischemia and mortality
in this series. Further investigation of this link between
LV-coronary fistula and mortality is required.
The presence of coronary fistula on preoperative imaging
studies should raise awareness of potentially increased mor-
tality risk, and optimal management strategies need to bediovascular Surgery c Volume 144, Number 6 1305
Congenital Heart Disease Nathan et alC
H
Ddeveloped. The roles of preferential use of a Sano shunt for
stage I palliation or a hybrid stage I palliation vs primary
transplantation for neonates with significant LV–coronary
fistulas should be considered in future management of pa-
tients with MS/AA and coronary fistula. Follow-up study
on survivors with coronary fistulas in HLHS will help us
gain a better understanding of the natural history of the cor-
onary fistula inasmuch as there has been a recent case report
of regression of fistula.25
We acknowledge Drs Stella and Richard Van Praagh since a sig-
nificant portion of these data were obtained from the Cardiac
Registry that they established and maintained. Their meticulous
clinical notes and autopsy reports provided invaluable
information.
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